GlassScriptPhysician profile
Mohindra Ramphal
NPI 1366794638
$2,504.12
in general payments reported to CMS, 2019-2025
17 companies · $775 in 2025
The $775 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.07 · 2020: $17.49 · 2021: $28.29 · 2022: $17.93 · 2023: $829 · 2024: $782 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,036 · Gift: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,036.34 |
| Gift | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $442.12 | 2022-2025 | Cequa, Xelpros |
| Alcon Vision LLC | $371.25 | 2023-2025 | Clareon, Rocklatan, Tryptyr |
| Abbvie INC. | $351.26 | 2023-2025 | |
| Visionary Optics LLC | $350.00 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $272.61 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $158.62 | 2024-2025 | Vevye |
| Bausch & Lomb Americas INC. | $155.50 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $125.00 | 2023-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $71.56 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $50.71 | 2023-2025 | Acthar |
| Dompe US, INC. | $50.05 | 2024-2025 | Oxervate |
| Amgen INC. | $25.68 | 2025 | Tepezza |
| Glaukos Corporation | $19.31 | 2023 | |
| Thea Pharma INC. | $17.16 | 2024 | |
| Johnson & Johnson Vision Care, INC. | $17.04 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oasis Medical, INC. | $15.00 | 2023 | Oasis Tears |
| Allergan, INC. | $11.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohindra Ramphal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.